In patients with type 2 diabetes (T2D), m6A levels were reduced, while the mRNA levels of FTO, METTL3, METTL14, WTAP were significantly elevated and involved in the pathogenesis of diabetes (51). This evidence concerns the gene METTL14 and diabetes mellitus.